Wellington Management Group LLP Trims Holdings in Phibro Animal Health Co. (NASDAQ:PAHC)

Wellington Management Group LLP reduced its stake in Phibro Animal Health Co. (NASDAQ:PAHC) by 24.7% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 88,343 shares of the company’s stock after selling 29,003 shares during the quarter. Wellington Management Group LLP owned approximately 0.22% of Phibro Animal Health worth $1,989,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Jacobs Levy Equity Management Inc. grew its holdings in shares of Phibro Animal Health by 116.6% in the third quarter. Jacobs Levy Equity Management Inc. now owns 192,255 shares of the company’s stock valued at $4,330,000 after purchasing an additional 103,491 shares during the period. BNP Paribas Financial Markets boosted its holdings in Phibro Animal Health by 3.1% in the 3rd quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock valued at $548,000 after purchasing an additional 729 shares during the last quarter. Quantbot Technologies LP purchased a new stake in shares of Phibro Animal Health in the 3rd quarter valued at approximately $70,000. FMR LLC grew its stake in shares of Phibro Animal Health by 22.7% in the 3rd quarter. FMR LLC now owns 39,310 shares of the company’s stock valued at $885,000 after buying an additional 7,270 shares during the period. Finally, Algert Global LLC increased its holdings in shares of Phibro Animal Health by 521.1% during the 3rd quarter. Algert Global LLC now owns 71,335 shares of the company’s stock worth $1,606,000 after buying an additional 59,850 shares during the last quarter. 99.34% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on PAHC shares. JPMorgan Chase & Co. initiated coverage on Phibro Animal Health in a report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 price objective on the stock. Barclays increased their price target on Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a report on Tuesday, November 12th. Morgan Stanley boosted their price objective on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a report on Tuesday. StockNews.com raised shares of Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a research note on Wednesday. Finally, Bank of America boosted their price target on shares of Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a research note on Friday, August 30th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Phibro Animal Health has an average rating of “Hold” and an average price target of $20.50.

Phibro Animal Health Stock Performance

Shares of Phibro Animal Health stock opened at $21.27 on Thursday. The stock has a market capitalization of $861.50 million, a price-to-earnings ratio of 49.47, a price-to-earnings-growth ratio of 0.58 and a beta of 0.51. The company has a debt-to-equity ratio of 1.81, a current ratio of 3.23 and a quick ratio of 1.69. The business has a 50-day moving average of $23.63 and a 200 day moving average of $20.66. Phibro Animal Health Co. has a 12 month low of $10.03 and a 12 month high of $25.98.

Phibro Animal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, December 18th. Investors of record on Wednesday, November 27th were issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.26%. The ex-dividend date of this dividend was Wednesday, November 27th. Phibro Animal Health’s dividend payout ratio (DPR) is currently 111.63%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.